Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Effect of vitamin D treatment on myogenic differentiation of human umbilical cord tissue-derived mesenchymal stem cells

ABSTRACT: Transcriptomic analysis of vitamin D-treated human umbilical cord tissue-derived mesenchymal stem cells that were differentiated for 7 days into the myogenic lineage

ORGANISM(S): Homo sapiens

PROVIDER: GSE157764 | GEO | 2021/10/01

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Human umbilical cord tissue is a robust source for mesenchymal stem cells with enhanced myogenic differentiation potential compared to cord blood

Project description:We report that mesenchymal stem cells isolated from umbilical cord tissue differentiate more robustly into the myogenic lineage compared to mesenchymal stem cells from cord blood isolated from the same individual

2020-11-10 | GSE147114 | GEO

Effect of vitamin D treatment on myogenic differentiation of human umbilical cord tissue-derived mesenchymal stem cells

Project description:Effect of vitamin D treatment on myogenic differentiation of human umbilical cord tissue-derived mesenchymal stem cells

| PRJNA662707 | ENA

Proteomic Analysis of Umbilical Cord and Adult Mesenchymal Stem Cells

Project description:Shotgun proteomic analysis was performed on lysates from umbilical cord and adjult mesenchymal stem cells

2022-12-19 | PXD032994 | Pride

Proteomic profiling of human mesenchymal stem cells derived from umbilical cord or adipose tissue

Project description:We performed a proteomic profiling of human mesenchymal stem cells (hMSCs) derived from adipose tissue or umbilical cord.

2018-07-11 | PXD009893 | Pride

Human umbilical cord blood-derived mesenchymal stem cells from 2 donors

Project description:screening of signature deterimes the individual variations in the therapeutic efficacy of human umbilical cord blood-derived mesenchymal stem cells There is paucity of information whether human umbilical cord blood-derived mesenchymal stem cells (hUCB-MSCs) from separate donors might have different effects on improving myocardial repair after myocardial infarction (MI).

2011-02-19 | GSE27414 | GEO

Gene expression of exosomes from human umbilical cord mesenchymal stem cells

Project description:To determine the gene expression of exosomes in human umbilical cord mesenchymal stem cells

2024-11-01 | GSE280447 | GEO

Human umbilical cord blood-derived mesenchymal stem cells from 2 donors

2011-02-19 | E-GEOD-27414 | biostudies-arrayexpress

Cellular and culture medium proteomes from umbilical cord mesenchymal stem cell and human umbilical vein endothelial cells

Project description:Application of umbilical cord mesenchymal stem cell-derived conditioned media (HUCMSC-CM) to treat severe, progressive PAH. Serial infusions of HUCMSC-CM resulted in marked clinical and hemodynamic improvement after 6 months, and showed no adverse events. Differential expression analysis between conditioned media and cells was used to identify molecular processes with a putative role in treatment benefit.

2022-11-29 | PXD032234 | Pride

Isolation and comparative analysis of mesenchymal stem cells from human umbilical cord

Project description:A non-controversial and non-invasive source of adult stem cells (ASCs), particularly hematopoietic stem cells (HSCs) and mesenchymal stem cells (MSCs) is human umbilical cord blood. HSCs derived from cord blood have been used for treating leukemia and other blood disorders for the last 30 years. While the presence of MSCs in cord blood is limited, umbilical cord has been found to be promising source of MSCs. However, the cord is an anatomically complex organ and potential isolation of MSCs from its various parts has not been fully explored. In this study we dissected the cord into cord placenta junction (CPJ), cord tissue (CT), and Wharton’s jelly (WJ) and isolated stem cells. These cells exhibited fibroid morphology, expressed MSC-specific markers including CD90, CD73, CD105, CD44, and CD29 and differentiated into chondrogenic, osteogenic, myogenic and neurogenic lineages. In addition, they all expressed pluripotency genes, OCT4, Nanog, Sox2 and KLF4 but expression of these markers was highest in CPJ followed by WJ and CT. CPJ-MSCs also had higher rate of proliferation compared to WJ- and CT-MSCs. Proliferation of WJ- and CT-MSCs was markedly decreased upon passaging with concomitant decrease in expression of MSC and pluripotency markers. Based on their greater self-renewal potential, CPJ-MSCs could be superior to WJ- and CT-MSCs for the applications in therapeutic and regenerative medicine.

2016-06-08 | GSE72597 | GEO

Expression data from human umbilical cord-derived mesenchymal stem cells

Project description:Mesenchymal stem cells (MSCs) have been shown to exert therapeutic effects on various autoimmune diseases. However, such therapeutic effect is not always achieved. Among many reasons, MSC culture methodologies may account for the these differences. It is known that oxygen concentration could profoundly affect the properties of MSCs. Therefore, we compared human umbilical cord derived MSCs cultured under hypoxic and normoxic conditions. We used microarrays to profile the gene expression of human umbilical cord derived MSCs under 10% oxygen and normoxia conditions.

2018-09-23 | GSE97773 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data